<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">JCO Precis Oncol</journal-id>
        <journal-id journal-id-type="pmc-domain-id">3882</journal-id>
        <journal-id journal-id-type="pmc-domain">jcopo</journal-id>
        <journal-id journal-id-type="publisher-id">PO</journal-id>
        <journal-title-group>
          <journal-title>JCO Precision Oncology</journal-title>
        </journal-title-group>
        <issn pub-type="epub">2473-4284</issn>
        <publisher>
          <publisher-name>American Society of Clinical Oncology</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC6345401</article-id>
        <article-id pub-id-type="pmcid-ver">PMC6345401.2</article-id>
        <article-id pub-id-type="pmcaid">6345401</article-id>
        <article-id pub-id-type="pmcaiid">7446360</article-id>
        <article-id pub-id-type="pmid">30687805</article-id>
        <article-id pub-id-type="doi">10.1200/PO.17.00267</article-id>
        <article-id pub-id-type="publisher-id">1700267</article-id>
        <article-version article-version-type="pmc-version">2</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Original Reports</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Raj</surname>
              <given-names initials="N">Nitya</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
            <xref ref-type="corresp" rid="cor2"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shah</surname>
              <given-names initials="R">Ronak</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Stadler</surname>
              <given-names initials="Z">Zsofia</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mukherjee</surname>
              <given-names initials="S">Semanti</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chou</surname>
              <given-names initials="J">Joanne</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Untch</surname>
              <given-names initials="B">Brian</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Li</surname>
              <given-names initials="J">Janet</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kelly</surname>
              <given-names initials="V">Virginia</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Osoba</surname>
              <given-names initials="M">Muyinat</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Saltz</surname>
              <given-names initials="LB">Leonard B.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mandelker</surname>
              <given-names initials="D">Diana</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ladanyi</surname>
              <given-names initials="M">Marc</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Klimstra</surname>
              <given-names initials="DS">David S.</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Reidy-Lagunes</surname>
              <given-names initials="D">Diane</given-names>
            </name>
            <xref ref-type="aff" rid="aff1"/>
          </contrib>
          <aff id="aff1"><bold>Nitya Raj</bold>, <bold>Ronak Shah</bold>, <bold>Zsofia Stadler</bold>, <bold>Semanti Mukherjee</bold>, <bold>Joanne Chou</bold>, <bold>Brian Untch</bold>, <bold>Janet Li</bold>, <bold>Virginia Kelly</bold>, <bold>Muyinat Osoba</bold>, <bold>Leonard B. Saltz</bold>, <bold>Diana Mandelker</bold>, <bold>Marc Ladanyi</bold>, <bold>Michael F. Berger</bold>, <bold>David S. Klimstra</bold>, and <bold>Diane Reidy-Lagunes</bold>, Memorial Sloan Kettering Cancer Center; and <bold>Muyinat Osoba</bold>, Columbia University College of Physicians and Surgeons, New York, NY.</aff>
        </contrib-group>
        <author-notes>
          <corresp id="cor2"><bold>Corresponding author:</bold> Nitya Raj, MD, Division of Gastrointestinal Medical Oncology, Memorial Sloan Kettering Cancer Center, 300 East 66th St, Room 1007, New York, NY 10065; e-mail: <email>rajn@mskcc.org</email>.</corresp>
        </author-notes>
        <pub-date pub-type="collection">
          <year>2018</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>19</day>
          <month>4</month>
          <year>2018</year>
        </pub-date>
        <volume>2</volume>
        <issue-id pub-id-type="pmc-issue-id">363911</issue-id>
        <elocation-id>PO.17.00267</elocation-id>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>19</day>
              <month>04</month>
              <year>2019</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>24</day>
              <month>01</month>
              <year>2019</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-02-08 18:25:11.160">
              <day>08</day>
              <month>02</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">6345401</article-id>
            <article-id pub-id-type="doi">10.1200/PO.17.00267</article-id>
            <article-id pub-id-type="manuscript-id">NIHMS979478</article-id>
            <article-version>1</article-version>
            <pub-date>
              <day>19</day>
              <month>04</month>
              <year>2018</year>
            </pub-date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">7446360</article-id>
            <article-id pub-id-type="doi">10.1200/PO.17.00267</article-id>
            <article-version>2</article-version>
            <pub-date>
              <day>19</day>
              <month>04</month>
              <year>2018</year>
            </pub-date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>Â© 2018 by American Society of Clinical Oncology</copyright-statement>
          <copyright-year>2018</copyright-year>
          <copyright-holder>American Society of Clinical Oncology</copyright-holder>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="PO.17.00267.pdf"/>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:title="pdf" xlink:href="PO.17.00267.pdf"/>
        <abstract>
          <sec id="s01">
            <title>Purpose</title>
            <p>We assessed the usefulness of real-time molecular profiling through next-generation sequencing (NGS) in predicting the tumor biology of advanced pancreatic neuroendocrine tumors (panNETs) and in characterizing genomic evolution.</p>
          </sec>
          <sec id="s02">
            <title>Methods</title>
            <p>Patients with metastatic panNETs were recruited in the routine clinical practice setting (between May 2014 and March 2017) for prospective NGS of their tumors as well as for germline analysis using the Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) sequencing platform. When possible, NGS was performed at multiple time points.</p>
          </sec>
          <sec id="s03">
            <title>Results</title>
            <p>NGS was performed in 96 tumor samples from 80 patients. Somatic alterations were identified in 76 of 80 patients (95%). The most commonly altered genes were <italic toggle="yes">MEN1</italic> (56%), <italic toggle="yes">DAXX</italic> (40%), <italic toggle="yes">ATRX</italic> (25%), and <italic toggle="yes">TSC2</italic> (25%). Alterations could be defined in pathways that included chromatin remodeling factors, histone methyltransferases, and mammalian target of rapamycin pathway genes. Somatic loss of heterozygosity was particularly prevalent (55 of 95 tested samples [58%]), and the presence of loss of heterozygosity resulted in improved overall survival (P = .06). Sequencing of pre- and post-treatment samples revealed tumor-grade progression; clonal evolution patterns were also seen (molecular resistance mechanisms and chemotherapy-associated mutagenesis). Germline genetic analysis identified clinically actionable pathogenic or likely pathogenic variants in 14 of 88 patients (16%), including mutations in high-penetrance cancer susceptibility genes (<italic toggle="yes">MEN1</italic>, <italic toggle="yes">TSC2</italic>, and <italic toggle="yes">VHL</italic>).</p>
          </sec>
          <sec id="s04">
            <title>Conclusion</title>
            <p>A clinical NGS platform reveals pertubations of biologic pathways in metastatic panNETs that may inform prognosis and direct therapies. Repeat sequencing at disease progression reveals increasing tumor grade and genetic evolution, demonstrating that panNETs adopt a more aggressive behavior through time and therapies. In addition to frequent somatic mutations in <italic toggle="yes">MEN1</italic> and <italic toggle="yes">TSC2</italic>, germline mutations in these same genes underlie susceptibility to panNETs and highlight the need to re-evaluate whether germline genetic analysis should be performed for all patients with panNETs.</p>
          </sec>
        </abstract>
        <counts>
          <fig-count count="9"/>
          <table-count count="3"/>
          <equation-count count="0"/>
          <ref-count count="44"/>
          <page-count count="18"/>
        </counts>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name> SJS Export </meta-name>
            <meta-value>v1</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
